4.5 Article

Polymorphisms in the GluR2 gene are not associated with amyotrophic lateral sclerosis

Journal

NEUROBIOLOGY OF AGING
Volume 33, Issue 2, Pages 418-420

Publisher

ELSEVIER SCIENCE INC
DOI: 10.1016/j.neurobiolaging.2010.03.007

Keywords

Amyotrophic lateral sclerosis; Excitotoxicity; GluR2; Motor neuron

Funding

  1. University of Leuven
  2. American ALS Association
  3. Belgian Science Policy Office (BELSPO) [P6/43]
  4. Jagiellonian University (Krakow, Poland) [nK/ZDS/001076]
  5. NIH, National Institute on Aging [Z01-AG000949-02]
  6. Packard Center for ALS Research
  7. E. von Behring Chair for Neuromuscular and Neurodegenerative Disorders
  8. Flanders Government
  9. ALS Therapy Alliance
  10. Angel Fund
  11. Pierre L. de Bourgknecht ALS Research Foundation
  12. Al-Athel ALS Research Foundation
  13. ALS Family Charitable Foundation
  14. National Institute for Neurological Disorders and Stroke
  15. Medical Research Council [G0000934]
  16. Wellcome Trust [068545/Z/02]
  17. MRC [G0600974, G0500289, G0900688, G0000934] Funding Source: UKRI
  18. Medical Research Council [G0900688, G0500289B, G0000934, G0600974, G0500289] Funding Source: researchfish

Ask authors/readers for more resources

Excitotoxicity is thought to play a pathogenic role in amyotrophic lateral sclerosis (ALS). Excitotoxic motor neuron death is mediated through the Ca(2+)-permeable alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid (AMPA)-type of glutamate receptors and Ca(2+) permeability is determined by the GluR2 subunit. We investigated whether polymorphisms or mutations in the GluR2 gene (GRIA2) predispose patients to ALS. Upon sequencing 24 patients and 24 controls no nonsynonymous coding variants were observed but 24 polymorphisms were identified, 9 of which were novel. In a screening set of 310 Belgian ALS cases and 794 healthy controls and a replication set of 3157 cases and 5397 controls from 6 additional populations no association with susceptibility, age at onset, or disease duration was observed. We conclude that polymorphisms in the GluR2 gene (GRIA2) are not a major contributory factor in the pathogenesis of ALS. (C) 2012 Elsevier Inc. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available